期刊文献+

福辛普利对糖尿病大鼠胰腺RAAS及胰岛功能的影响 被引量:4

Effects of fosinopril on renin-angiotensin-aldosterone system and pancreatic islet function in diabetic rats
原文传递
导出
摘要 目的研究福辛普利对糖尿病大鼠胰腺肾素血管紧张肽醛固酮系统(RAAS)及胰岛功能的影响。方法链脲佐菌素(STZ)联合高脂高糖饮食制作糖尿病大鼠动物模型,造模成功者随机分为模型组和用药组,每组7只;同时随机选取7只正常大鼠作为对照组。用药组在造模成功后给予福辛普利500mg·kg-1·d-1灌胃,其余2组予等量蒸馏水代替。8wk后测定血糖、血胰岛素和胰腺血管紧张肽Ⅰ(AngⅠ)、血管紧张肽Ⅱ(AngⅡ)和醛固酮(ALD)含量,免疫组化方法观察胰腺组织胰岛素的表达。结果与模型组相比,用药组大鼠体重明显增长,血胰岛素水平及β细胞分泌指数上升,空腹血糖明显下降,胰腺组织中AngⅠ、AngⅡ含量明显下降(P<0.05),ALD含量无显著差异。用药组胰腺各分泌细胞排列、分布趋于均匀,胰岛素表达较模型组增多。结论福辛普利可降低胰腺AngⅠ、AngⅡ的含量,改善胰岛功能。 AIM To study the effects of fosinopril on renin-angiotensin-aldosterone system (RAAS) and pancreatic islet function in diabetic rats. METHODS Rat models of type 2 diabetes mellitus were induced by streptozotocin combined with high fat and high sucrose diet, the successful models were randomly divided into model group and fosinopril treated group (n = 7); while 7 normal rats were randomly chosen as control group. After the model was successfully constructed, rats in the control group and model group were peffused with distilled water, and rats in fosinopril treated group was administered with fosinopril (500 mg·kg^-1·d^-1) for 8 weeks. The fasting blood glucose (FBG), fasting insuline, angiotensin I (Ang I ), angiotensin Ⅱ (Ang Ⅱ ) and aldosterone (ALD) were tested, and the expression of insulin was observed by immunohistochemistry method. RESULTS Compared with the model group, the weight, blood insulin level, and the secretion index of β cellsincreased remarkably, and FBG, the content of Ang I and Ang Ⅱ decreased significantly in fosinopril treated group (P 〈 0.05). There was no significant difference of ALD between two groups. The immunohistochemistry method showed that the organization and distribution of secretory cells were uniform in the fosinopril treated group, and the expression of insulin in the fosinopril treated group was more than that in the model group. CONCLUSION Fosinopril could decrease the concentration of Ang I, Ang Ⅱ, and improve the pancreas function.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2009年第7期526-529,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 糖尿病 胰腺 胰岛 福辛普利 肾素血管紧张素醛固酮系统 diabetes mellitus pancreas islets of langerhans fosinopril renin-angiotensin-aldosterone system
  • 相关文献

参考文献2

二级参考文献32

  • 1CAO Z, BONNET F, DAVIS B, et al. Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats [J]. Clin Sci, 2001, 100(6) :591-599.
  • 2KURIYAMA S, TOMONARI H, ABE A, et al. Beneficial effect of combination therapy with an angiotensin Ⅱ receptor antagonist and angiotensin-converting enzyme inhibitior on overt proteinuria in a patient with type 1 diabetic nephropathy [J]. Nephron, 2000, 86(4): 529-530.
  • 3RUSSO D, PISANI A, BALLETTA MM, et al. Addictive antiproteinuric effect of convertingenzyme inhibitor and losartan in normotensive patients with IgA nephropathy [J]. Am J Kidney Dis,1999, 33 (5) :851-856.
  • 4Nakayama M, Inoguchi T, Sonta T, Maeda Y, Sasaki S, Sawada F, et al. Increased expression of Nad(P)H oxidase in islets of animal models of type 2 diabetes and its improvement by an At1 receptor antagonist. Biochem Biophys Res Commun 2005; 332: 927-33.
  • 5Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 2005; 26: 271-9.
  • 6Kosugi M, Miyajima A, Kikuchi E, Horiguchi Y, Murai M. Angiotensin Ⅱ type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer. Clin Cancer Res 2006; 12: 2888-93.
  • 7Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin-angiotensin system in the Zdf rat. Diabetes 2004; 53: 989-97.
  • 8Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 2002; 45: 85-96.
  • 9Oliveira HR, Verlengia R, Carvalho CR, Britto LR, Curi R, Carpinelli AR. Pancreatic beta-cells express phagocyte-like Nad(P)H oxidase. Diabetes 2003; 52: 1457-63.
  • 10Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlof B, et al. Risk of new-onset diabetes in the losartan intervention for endpoint reduction in hypertension study. J Hypertens 2002; 20: 1879-86.

共引文献14

同被引文献58

  • 1刘兴莲,黄星原,张敏.实验性病毒性心肌炎小鼠中核因子κB、单核细胞趋化蛋白-1的表达及意义[J].中国临床康复,2004,8(30):6622-6624. 被引量:3
  • 2钱祝银,刘训良,杜竞辉.NF-κB与急性胰腺炎[J].中国现代普通外科进展,2001,4(2):75-77. 被引量:2
  • 3荀运浩,项柏康.胰腺局部组织肾素-血管紧张素-醛固酮系统与胰腺炎[J].国外医学(消化系疾病分册),2005,25(4):212-214. 被引量:1
  • 4张雪晗,曾正陪,李汉忠,周亚茹,张晶,童安莉,阎朝丽.肾素-血管紧张素-醛固酮系统中不同组分在脂肪组织中的表达[J].中国医学科学院学报,2006,28(6):766-769. 被引量:10
  • 5Hasegawa G, Fukui M, Hosoda H, et al. Telmisartan, an an- giotensin II type 1 receptor blocker,prevents the development of diabetes in male Spontaneously Diabetic Torii rats. Eur J Pharmacol, 2009,605 : 164-169.
  • 6Chen J, Saxena G, Mungrue IN, et al. Thioredoxin-interacting protein:a critical link between glucose toxicity and beta-cell apoptosis. Diabetes, 2008,57 : 938-944.
  • 7Nishiyama A, Matsui M, Iwata S, et al. Identification of thiore- doxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expres- sion. J Biol Chem, 1999 274 : 21645-21650.
  • 8Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and bio- chemical mechanisms. Diabetes Metab, 2004,30 : 498-505.
  • 9Nakayama M, Inoguchi T, Sonta T, et al. Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 dia- betes and its improvement by an AT1 receptor antagonist. Biochem Biophys Res Commun, 2005,332,927-933.
  • 10Hotta M, Tashiro F, Ikegami H, et al. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapop- totic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp IVied, 1998,188:1445-1451.

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部